AC Immune ACIU
NASDAQ ACIU
$2.49 +0.06 (+2.26%)
At close: Oct 20, 2026 · 4:00 PM EDT

AC Immune (ACIU) Current Assets (2014 - 2026)

Updated

AC Immune's Current Assets came in at $118.17 million for the quarter ended Jun 30, 2026, down 25.8% from $159.21 million a year earlier but up 15.6% from the prior quarter.

Analysis

AC Immune (ACIU) Current Assets (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, AC Immune's Current Assets was $116.66 million, down 40.3% from the prior year.

  • Current Assets carries a five-year compound annual growth rate of -13.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Current Assets was $195.51 million in the year ended Dec 31, 2024 (+40.3%), $139.35 million in the year ended Dec 31, 2023 (+3.8%), $134.28 million in the year ended Dec 31, 2022 (-39.4%) and $221.75 million in the year ended Dec 31, 2021 (-10.3%).
  • The five-year range for quarterly Current Assets is $97.57 million (the quarter ended Sep 30, 2023) to $219.76 million (the quarter ended Dec 31, 2021).
  • Year-over-year, Current Assets has declined for five consecutive quarters, with growth averaging 4.6% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in the quarter ended Sep 30, 2024 (growth of 121.9%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 39.6%).
  • Business Quant data shows ACIU's Current Assets at $102.23 million (quarter ended Mar 31, 2026), $121.02 million (quarter ended Dec 31, 2025) and $142.19 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 59.77 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.67 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 13.95 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 41.36 Bn
10 AC Immune 250.37 Mn -188.03 Mn - 115.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115.65 Mn
Mar 31, 2026 100.08 Mn
Dec 31, 2025 122.17 Mn
Sep 30, 2025 142.68 Mn
Jun 30, 2025 165.12 Mn
Mar 31, 2025 172.71 Mn
Dec 31, 2024 190.42 Mn
Sep 30, 2024 223.19 Mn
Jun 30, 2024 200.93 Mn
Mar 31, 2024 121.94 Mn
Dec 31, 2023 148.40 Mn
Sep 30, 2023 94.21 Mn
Jun 30, 2023 110.27 Mn
Mar 31, 2023 122.28 Mn
Dec 31, 2022 138.80 Mn
Sep 30, 2022 151.40 Mn
Jun 30, 2022 165.99 Mn
Mar 31, 2022 191.84 Mn
Dec 31, 2021 221.77 Mn
Sep 30, 2021 209.13 Mn
API Access

AC Immune Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ACIU&period=max&api_key=YOUR_API_KEY